The microbiome—a vast ecosystem of microbes within our bodies—is emerging as a foundational platform for health, influencing everything from immunity and digestion to mental health and drug response. Despite growing scientific evidence, the healthcare industry often treats it as a niche trend, limiting its potential. The article argues for a paradigm shift: to stop viewing the microbiome as a wellness product and start integrating it into diagnostics, chronic care, and personalized medicine. The future of healthcare, it suggests, may depend not on external innovation, but on unlocking the power of the microscopic world within us.
Trending
- AI-Assisted Colonoscopy and the Diminutive Adenoma Dilemma (Los Angeles Times)
- BE Surveillance, Outpatient ESD, and More (GI & Endoscopy News)
- HHS-OIG Issues Favorable Advisory Opinion for Free Multi-Cancer Detection Supplemental Reports Provided with Medicare-Covered Colorectal Cancer Screening Tests (The National Law Review)
- Physician–researcher’s work yields landmark five-year data for Crohn’s disease drug (Medical Xpress)
- CU Anschutz Biobank Partners with Tech Company to Advance Gut Research and Patient Care (The Regents of the University of Colorado)
- Novant Health adds leading gastroenterology clinicians to its Lowcountry network (Novant Health)
- Solutions Emerging for Post-GLP-1 Weight Regain (Medscape)
- CMS Grants Medicare Coverage for ColoSense®, Expanding Access to Simplified Noninvasive Colorectal Cancer Screening (Business Wire)
